Search

everythinglearnresearchcommunity

for

Search:↓

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

ILC1 cells contribute to hair loss in alopecia areata.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Leflunomide is more likely to help treat alopecia areata than cause it.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

TNF-alpha inhibitors can cause various immune-related skin issues.